市场调查报告书
商品编码
1237822
血糖监测设备市场规模、副产品、应用、分销渠道、行业分析报告、区域展望、增长潜力、竞争对手市场份额和预测,2023-2032 年Self-monitoring Blood Glucose Devices Market Size, By Product, By Application, By Distribution Channel, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032 |
由于自我监控的不断创新,预计自我监控市场将在 2023 年至 2032 年期间获得巨大发展势头。
技术进步有望提供更简单、更便携、更方便的检测设备,这些设备将在胰岛素依赖型糖尿病患者中更受欢迎。
用于血糖监测的自我监测技术已成为主流,因为它们已被证明对糖尿病患者实用且方便。 据可靠报导,到2045年,全球将有超过7亿人患有糖尿病。
总体而言,血糖仪行业在产品、应用、分销渠道和区域方面存在细分。
按产品划分,到 2032 年,血糖仪细分市场的复合年增长率预计将超过 14.5%。 这种增长主要是由于这些血糖仪在家庭环境中提供的便利。 主要製造商推出的新产品也将对该细分市场的扩张产生积极影响。
根据应用,到 2032 年,1 型糖尿病的价值预计将超过 24 亿美元。 持续监测血糖水平以管理 1 型糖尿病患者剂量的需求日益增加,预计这将带来可观的市场回报。 根据该报告,2021 年将有超过 840 万 1 型糖尿病患者。
按销售渠道划分,预计医院药房部门将在预计期间实现强劲增长。 糖尿病患病率的上升和老年人口的易感性增加以及因疾病管理而增加的医院就诊率预计将在未来几年推动这一细分市场的采用。 医院药房中创新和先进的自我监测设备的可用性也将提升这一领域的增长潜力。
按地区划分,到 2032 年,亚太地区自我监测设备市场的价值预计将超过 130 亿美元。 该地区老年人口的增加和糖尿病患者的激增被认为为 SMBG 设备市场提供了有利可图的增长机会。 此外,不断推出新产品的行业巨头的存在将支持该地区的扩张。 此外,增加医疗保健支出和政府为减轻糖尿病负担所做的努力将进一步推动对 SMBG 设备的需求。
Self-monitoring Blood Glucose Monitoring Devices Market is anticipated to garner substantial momentum during 2023-2032 owing to the constant technological innovations in self-monitoring blood glucose devices. Advancements in technology offer easier, more portable, and more convenient testing devices that are anticipated to increase its popularity among insulin-dependent diabetes patients.
Self-monitoring technologies for blood glucose monitoring have become mainstream as they have proven to be pragmatic and convenient for diabetic population. According to credible reports, by 2045, more than 700 million people across the world will have diabetes.
Overall, the self-monitoring blood glucose monitoring devices industry is segmented in terms of product, application, distribution channel, and region.
Based on the product, the self-monitoring blood glucose meters segment is estimated to grow at over 14.5% CAGR through 2032. The growth will be majorly due to the convenience offered by these meters in home settings. Besides, the ongoing launch of new products by the major giants will also positively influence segment expansion.
Considering the application, the type 1 diabetes segment is anticipated to be valued at over $2.4 billion by 2032. The rising need for continuous monitoring of blood glucose levels among patients with type 1 diabetes to manage the dosing, will generate significant market revenue. As per reports, there were more than 8.4 million individuals living with type 1 diabetes in 2021.
By distribution channel, the hospital pharmacies segment is slated to register strong growth during the estimated timeframe. The increasing prevalence of diabetes and high susceptibility in the elderly population, coupled with a rise in hospital visits to manage the disease, will drive segment adoption in the ensuing years. Besides, the availability of innovative and advanced self-monitoring blood glucose devices at hospital pharmacies will stimulate the segment growth potential.
Regionally, the Asia Pacific self-monitoring blood glucose monitoring devices market is anticipated to be valued at over USD 13 billion by 2032. Growing geriatric population base and constantly surging cases of diabetes in the region will offer lucrative growth opportunities to the SMBG device market. The presence of some leading industry players, who are constantly working on launching new products, will support regional expansion. In addition, increasing healthcare expenditure and government initiatives to reduce the burden of the disease will further drive the SMBG device demand.